Resverlogix Corp. (RVX-T) Stock Predictions - Stockchase
WATCH LIST
5
Resverlogix Corp. (RVX-T)

ON STOCKCHASE SINCE Jan 2007

Treatment of Cardiovascular diseases

biotechnology/pharmaceutical

Resverlogix Corp.

RVX-T

4 watching          
Join the Discussion

Resverlogix Corp. (RVX-T) SAVE Apr, 24, 2019, 9:50 pm

3.99 0.16 (3.86%)

What the experts are saying about RVX-T



  • All
  • Filtered
Signal Opinion Expert
COMMENT
Resverlogix Corp.(RVX-T) 

November 16, 2009

(Market Call Minute.)Reversing of bad cholesterol in clinical studies. A little early for him but has potential. Speculative.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
(Market Call Minute.)Reversing of bad cholesterol in clinical studies. A little early for him but has potential. Speculative.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Peter Hodson

CEO & Head, 5i Research Inc....

Price Price
$2.580
Owned Owned
No

COMMENT
Resverlogix Corp.(RVX-T) 

August 6, 2009

Only process that can reverse a cholesterol situation. A lot of big pharmas are looking at the name. Looks pretty attractive at this level. This is at phase 2 and he prefers buying after phase 3.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Only process that can reverse a cholesterol situation. A lot of big pharmas are looking at the name. Looks pretty attractive at this level. This is at phase 2 and he prefers buying after phase 3.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Peter Hodson

CEO & Head, 5i Research Inc....

Price Price
$2.790
Owned Owned
No

COMMENT
Resverlogix Corp.(RVX-T) 

December 27, 2007

Have some compounds that are expected to boost HDL levels significantly. He usually has trouble with pure biotechs, which this one is. They consume vast amounts of cash. Prefers Neptune (NTB-X).
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Have some compounds that are expected to boost HDL levels significantly. He usually has trouble with pure biotechs, which this one is. They consume vast amounts of cash. Prefers Neptune (NTB-X).
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Hugh Cleland, C

Founding P, Northern Rivers Capi...

Price Price
$15.420
Owned Owned
No

DON'T BUY
Resverlogix Corp.(RVX-T) 

March 26, 2007

Strong management. Have an interesting approach to HDL. Currently pre-clinical, so doesn't know if it works in humans or is safe.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Strong management. Have an interesting approach to HDL. Currently pre-clinical, so doesn't know if it works in humans or is safe.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Hugh Cleland, C

Founding P, Northern Rivers Capi...

Price Price
$16.900
Owned Owned
No

DON'T BUY
Resverlogix Corp.(RVX-T) 

January 24, 2007

Treatment of Cardiovascular diseases. They’re on to a new way of looking at HDL treatment. Still pre-clinical. Prefers biotech that is at least in phase 2 trials. Too expensive.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Treatment of Cardiovascular diseases. They’re on to a new way of looking at HDL treatment. Still pre-clinical. Prefers biotech that is at least in phase 2 trials. Too expensive.
biotechnology/pharmaceutical
0 0 0 0 0
0 comments
Hugh Cleland, C

Founding P, Northern Rivers Capi...

Price Price
$19.110
Owned Owned
No

Showing 1 to 5 of 5 entries
Successfully Saved Company
Successfully Saved Company